Approximately 700,000 human deaths are attributable to antimicrobial resistance (AMR) each year globally. If trends continue, 350 million cumulative deaths are estimated to be caused by AMR by 2050. Without breakthrough research and interventions, we risk an unthinkable return to an era of untreatable infectious diseases. In response to this serious health and security threat, we are establishing the Tufts Center for Integrated Management of Antimicrobial Resistance to combat antimicrobial resistant infections. This sobering yet optimistic LEAD IT panel discussion will describe some of the groundbreaking research of Tufts investigators in this area.
John Leong, M.D., Ph.D., Edith Rieva and Hyman S. Trilling Professor of Molecular Biology and Microbiology, chair of molecular biology and microbiology, School of Medicine
Caroline Genco, Ph.D., Arthur E. Spiller Professor and chair of immunology, School of Medicine
Amy Pickering, Ph.D., assistant professor civil and environmental engineering, School of Engineering
Bree Aldridge, Ph.D., adjunct assistant professor biomedical engineering, School of Engineering and assistant professor, molecular biology and microbiology, School of Medicine
Helen Boucher, M.D., Division of Geographic Medicine and Infectious Disease, Tufts Medical Center